Contraception
Volume 80, Issue 6 , Pages 540-554, December 2009

The EVAPIL® scale, a new tool to assess tolerance of oral contraceptives

  • Olivier Graesslin

      Affiliations

    • Centre Hospitalier Universitaire, Institut Mère Enfant Alix de Champagne, Service de Gynécologie-Obstétrique, F-51092 Reims, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 3 26 78 35 17; fax: +33 3 26 78 38 39.
  • ,
  • Philippe Barjot

      Affiliations

    • Service de Gynécologie-Obstétrique, Polyclinique du Parc, F-14052 Caen cedex 04, France
  • ,
  • Médéric Hoffet

      Affiliations

    • Service de Gynécologie-Obstétrique, CHU Carremeau, place du Professeur Robert Debré, F-30029 Nîmes cedex 09, France
  • ,
  • Daniel Cohen

      Affiliations

    • Service de Gynécologie-Obstétrique, Centre Hospitalier du Pays d'Aix, F-13616 Aix-en-Provence cedex 01, France
  • ,
  • Philippe Vaillant

      Affiliations

    • Service de Gynécologie-Obstétrique, Centre Hospitalier Laënnec, F-60109 Creil cedex, France
  • ,
  • Pierre Clerson

      Affiliations

    • Orgamétrie Biostatistiques, F-59100 Roubaix, France

Received 25 May 2008; received in revised form 15 April 2009; accepted 5 June 2009. published online 23 July 2009.

Abstract 

Background

The EVAPIL® scale is a self-questionnaire aimed to assess tolerability of oral contraceptives (OC).

Methods

For initial development: a list of questions addressing the more frequent or more unpleasant minor side effects of OC was developed by a group of gynecologists and submitted to several sets of OC users. A final version with 14 questions was issued with scoring rules.

For validation, the EVAPIL® scale was submitted to 3502 women who were OC users for at least 6 months to evaluate internal consistency and factorial structure. Test-retest reproducibility was studied 30 days apart in 53 other OC users.

Results

Internal consistency was good (Cronbach's alpha .71) without redundant questions. Principal components analysis with Varimax rotation was used to summarise information given by the 14 questions in a smaller number of multivariate dimensions. Dimension 1 explained 22% of the total variance, strongly correlated with all symptoms except oily skin, acne and cycle control. Dimension 2 accounted for 10% of the total variance and was correlated with oily skin and acne. Dimensions 3 and 4 were better correlated with cycle control. Reproducibility was excellent (intraclass correlation 0.88). The EVAPIL® scale was found easy to use and took no more than 5 min to complete.

Conclusion

The EVAPIL® scale demonstrated interesting psychometric properties to evaluate the tolerability of OCs in OC users. Further research is needed to address sensitivity to change and usefulness in new OC users.

Keywords: Contraceptives, Tolerance, Acceptability, Assessment, EVAPIL®

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0010-7824(09)00307-2

doi:10.1016/j.contraception.2009.06.008

Contraception
Volume 80, Issue 6 , Pages 540-554, December 2009